Ablynx goes to the market in 2018
With over 45 research projects VUB spin-off Ablynx has a full pipeline at its disposal. Eight of these projects are already in the clinical development stage. In 2018 the biotech company, located in Ghent, hopes to introduce a first drug into the market.
More info and the full article in trends can be found here.